MedPath

A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.

Phase 2
Completed
Conditions
HIV Infections
Cytopenias
Registration Number
NCT00002126
Lead Sponsor
Amgen
Brief Summary

To determine, in HIV-infected patients, the efficacy of filgrastim ( recombinant-methionyl human granulocyte-colony stimulating factor; G-CSF ) in preventing grade 4 neutropenia, i.e., absolute neutrophil count (ANC) \< 500 cells/mm3.

Detailed Description

Patients are randomized to receive subcutaneous G-CSF at one of two different doses or no G-CSF (observation) for 24 weeks. Patients who experience ANC \< 500 cells/mm3 on two consecutive occasions at least 24 hours apart prior to completing the 24-week study period will be considered to have reached the primary study endpoint; those in the observation group who reach the primary endpoint prior to week 24 may begin receiving G-CSF for the remainder of the study period. After 24 weeks, patients may continue G-CSF on a compassionate basis at the investigator's discretion.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
250
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (22)

Univ of Alabama at Birmingham / AIDS Outpatient Clinic

🇺🇸

Birmingham, Alabama, United States

Maricopa County Med Ctr

🇺🇸

Phoenix, Arizona, United States

CARE Ctr / UCLA Med Ctr

🇺🇸

Los Angeles, California, United States

UCSF - San Francisco Gen Hosp

🇺🇸

San Francisco, California, United States

Univ Hosp / Univ of Colorado Health Sci Ctr

🇺🇸

Denver, Colorado, United States

George Washington Univ Med Ctr

🇺🇸

Washington, District of Columbia, United States

TheraFirst Med Ctrs Inc

🇺🇸

Fort Lauderdale, Florida, United States

Rush Presbyterian - Saint Luke's Med Ctr

🇺🇸

Chicago, Illinois, United States

Univ of Kansas School of Medicine

🇺🇸

Wichita, Kansas, United States

Tulane Univ Med School

🇺🇸

New Orleans, Louisiana, United States

Scroll for more (12 remaining)
Univ of Alabama at Birmingham / AIDS Outpatient Clinic
🇺🇸Birmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.